by EpicentRx | Oct 4, 2024 | Blog
The first meeting of the minds occurred on Saturday, September 28th from 1:30-2:30 pm EST at the 2024 International Congress of Parkinson’s Disease and Movement Disorders (MDS) in Philadelphia, Pennsylvania. During a one-hour platform presentation, Associate Professor...
by EpicentRx | Oct 3, 2024 | Blog
The era of quantum computing is here. But what is quantum computing and how does quantum differ from “classical” digital computing? Well, we’re certainly no experts, but from our limited understanding, conventional computers use transistors that only store...
by EpicentRx | Oct 2, 2024 | Blog
Two patents entitled “Methods and Compositions Utilizing RRx-001 for Radioprotection” and “Cytokine Receptor Fusion Proteins (TGF-beta trap) and Virus Expressing Them” were recently issued in several countries, which is always a cause for celebration. The purpose of...
by EpicentRx | Oct 1, 2024 | Blog
Seeing is believing, right? Not always in the case of lead EpicentRx therapy, AdAPT-001. In a recent manuscript published in the prestigious journal, Journal of Immunotherapy in Cancer (JITC), entitled “AdAPT-001 and pseudoprogression – when seeing is not necessarily...
by EpicentRx | Sep 30, 2024 | Blog
It was no “Rocky” start for Associate Professor, Dr. Richard Gordon from Queensland, Australia, at the 2024 International Parkinson and Movement Disorder Society (MDS) Conference in Philadelphia, Pennsylvania. He delivered a well-attended oral presentation on the...
